These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31494348)

  • 1. How to identify and manage non-response to clozapine?
    Shad MU; Felzien E; Roy K; Sethi S
    Asian J Psychiatr; 2019 Oct; 45():50-52. PubMed ID: 31494348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
    Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
    Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing nonresponse in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2012 Feb; 73(2):e07. PubMed ID: 22401484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study.
    Kho KH; Blansjaar BA; de Vries S; Babuskova D; Zwinderman AH; Linszen DH
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):372-9. PubMed ID: 15538604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
    Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
    Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study.
    Petrides G; Malur C; Braga RJ; Bailine SH; Schooler NR; Malhotra AK; Kane JM; Sanghani S; Goldberg TE; John M; Mendelowitz A
    Am J Psychiatry; 2015 Jan; 172(1):52-8. PubMed ID: 25157964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
    Benatov R; Sirota P; Megged S
    Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment-refractory schizophrenia in children and adolescents: an update on clozapine and other pharmacologic interventions.
    Kranzler HN; Kester HM; Gerbino-Rosen G; Henderson IN; Youngerman J; Beauzile G; Ditkowsky K; Kumra S
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):135-59. PubMed ID: 16321728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series].
    Kalenderoğlu A; Çelik M
    Turk Psikiyatri Derg; 2016; 27(1):57-62. PubMed ID: 27369686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy of a patient treated with clozapine.
    Dickson RA; Hogg L
    Psychiatr Serv; 1998 Aug; 49(8):1081-3. PubMed ID: 9712217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clozapine in the treatment of under-age schizophrenia].
    Haapasalo-Pesu KM
    Duodecim; 2009; 125(15):1635-8. PubMed ID: 19769179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very high cytochrome P4501A2 activity and nonresponse to clozapine.
    Bender S; Eap CB
    Arch Gen Psychiatry; 1998 Nov; 55(11):1048-50. PubMed ID: 9819075
    [No Abstract]   [Full Text] [Related]  

  • 17. Clozapine in schizophrenia patients with recurrent catatonia: report of two cases.
    Hung YY; Yang PS; Huang TL
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):256-8. PubMed ID: 16594953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia.
    Qurashi I; Collins JD; Chaudhry IB; Husain N
    J Psychopharmacol; 2014 Jul; 28(7):707-8. PubMed ID: 24646811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report.
    Sangüesa E; Cirujeda C; Concha J; Padilla PP; Ribate MP; García CB
    Pharmacogenomics; 2019 Aug; 20(12):871-877. PubMed ID: 31453772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learned lessons from patients who take clozapine: A case study.
    Lee H; Scolieri BB; Mullick PK
    Perspect Psychiatr Care; 2018 Oct; 54(4):457-461. PubMed ID: 28926097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.